Clinical Trials
2 trialsNCT05001724 2023-04-25
KN046 Plus Lenvatinib in Subject With Advanced Non-Small Cell Lung Cancer in the Failure of Anti-PD-(L)1 Agent
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 2/3 Terminated
NCT02200354 2019-08-14
The Safety and Efficacy of Pemetrexed Rechallenge With Bevacizumab
Kobe City General Hospital
Phase 2 Terminated